Ms. Alon joined Pitango in 1998. With over 26 years of international experience in the high-tech medical industry, Ms. Ruth Alon heads the life sciences activities at Pitango.

Ms. Alon previously worked on Wall Street where she held senior positions with Montgomery Securities and Kidder Peabody & Co. As a senior medical device analyst, Ms. Alon was rated as one of the top in her field for four consecutive years. She also managed her own independent consulting business in San Francisco, providing broad-based services to early-stage companies and venture capitalists in the medical devices industry.

Ms. Alon has a B.A. in Economics from the Hebrew University of Jerusalem, an M.B.A. from Boston University, and an M.S. from the Columbia University School of Physicians and Surgeons.

Mr. Gross is a co-founder of TransPharma, and participates and advises in the company’s research and development activities. Mr. Gross was Vice President of Research & Development at Elan Medical Technologies (Israel) Ltd., a subsidiary of Elan Corporation, a world leader in advanced drug delivery systems. From 1988 to 1995, Mr. Gross directed the research and development operations of Scientific Innovations Ltd. Between 1977 and 1985, he served in key management positions in the Engineering Division of Israel Aircraft Industries. Mr. Gross has over 100 patents registered in his name. He received an M.Sc. degree in Aeronautical Engineering from the Technion - Israel Institute of Technology in 1976.

Monique Laliberté joined the Caisse in 2002 and currently assumes the position of Portfolio manager, Private Equity. Ms. Laliberté has more than 25 years of experience in business development, financial, strategic and scientific valuation in the life sciences sector. Prior to assuming this position, Ms. Laliberté was a member of the Caisse’s Mid-Sized Businesses team. Ms. Laliberté held various positions in the Private Equity group, notably with the Fund Management and Venture Capital teams. Previously, she was Vice-President, Biotechnology, Pharmaceuticals and Health Care at KPMG Corporate Finance. She was also Vice-President with Milestone Medica Corporation, Director, Business Development at Æterna Laboratories, Project Manager, Industrial Affairs at the Biotechnology Research Institute of the National Research Council of Canada and a Microbiology Research Associate at Allelix. Ms. Laliberté has been a member of the Québec venture capital association Réseau Capital for several years and has served on its Board since 2008. Ms. Laliberté is also the author of several scientific articles. She holds an MBA from HEC Montréal, an M.Sc. from Université Laval and a Bachelor of Science in Microbiology and Immunology from McGill University.